Advertisement

Atorvastatin Tablets

[20 May 2015]

Products Affected - Description

Atorvastatin tablets, Apotex
10 mg, 90 count (NDC 60505-2578-09)
10 mg, 1000 count (NDC 60505-2578-08)
20 mg, 90 count (NDC 60505-2579-09)
20 mg, 1000 count (NDC 60505-2579-08)
40 mg, 90 count (NDC 60505-2580-09)
40 mg, 1000 count (NDC 60505-2580-08)
80 mg, 90 count (NDC 60505-2671-09)
80 mg, 1000 count (NDC 60505-2671-08)
 
Atorvastatin tablets, Greenstone
10 mg, 90 count (NDC 59762-0155-01)
10 mg, 1000 count (NDC 59762-0155-02)
20 mg, 90 count (NDC 59762-0156-01)
20 mg, 1000 count (NDC 59762-0156-02)
40 mg, 90 count (NDC 59762-0157-01)
40 mg, 500 count (NDC 59762-0157-02)
80 mg, 90 count (NDC 59762-0158-01)
80 mg, 500 count (NDC 59762-0158-02)
 
Atorvastatin tablets, Ranbaxy
10 mg, 90 count (NDC 63304-0827-90) - discontinued
10 mg, 500 count (NDC 63304-0827-05) - discontinued
20 mg, 90 count (NDC 63304-0828-90) - discontinued
20 mg, 500 count (NDC 63304-0828-05) - discontinued
40 mg, 90 count (NDC 63304-0829-90) - discontinued
40 mg, 500 count (NDC 63304-0829-05) - discontinued
80 mg, 90 count (NDC 63304-0830-90) - discontinued
80 mg, 500 count (NDC 63304-0830-05) - discontinued
 
Atorvastatin tablets, Sandoz
40 mg, 90 count (NDC 00781-5384-92)
80 mg, 90 count (NDC 00781-5388-92)

Reason for the Shortage

  • Ranbaxy discontinued atorvastatin in late-2014.
  • Apotex has atorvastatin tablets on allocation due to increased demand.
  • Greenstone and Sandoz state the shortage is due to demand exceeding supply.

Available Products

Atorvastatin tablets, Dr. Reddy’s
10 mg, 90 count (NDC 55111-0121-90)
10 mg, 500 count (NDC 55111-0121-05)
20 mg, 90 count (NDC 55111-0122-90)
20 mg, 500 count (NDC 55111-0122-05)
40 mg, 90 count (NDC 55111-0123-90)
40 mg, 500 count (NDC 55111-0123-05)
80 mg, 90 count (NDC 55111-0124-90)
80 mg, 500 count (NDC 55111-0124-05)
 
Atorvastatin tablets, Kremers Urban
10 mg, 90 count (NDC 62175-0890-46)
10 mg, 1000 count (NDC 62175-0890-43)
20 mg, 90 count (NDC 62175-0891-46)
20 mg, 1000 count (NDC 62175-0891-43)
40 mg, 500 count (NDC 62175-0892-46)
40 mg, 90 count (NDC 62175-0892-41)
80 mg, 90 count (NDC 62175-0897-46)
80 mg, 500 count (NDC 62175-0897-41)
 
Atorvastatin tablets, Major
10 mg, 100 count (NDC 00904-6290-61)
20 mg, 100 count (NDC 00904-6291-61)
 
Atorvastatin tablets, Mylan
10 mg, 90 count (NDC 00378-3950-77)
10 mg, 500 count (NDC 00378-3950-05)
20 mg, 90 count (NDC 00378-3951-77)
20 mg, 500 count (NDC 00378-3951-05)
40 mg, 500 count (NDC 00378-3952-05)
40 mg, 90 count (NDC 00378-3952-77)
80 mg, 90 count (NDC 00378-3953-77)
80 mg, 500 count (NDC 00378-3953-05)
 
Atorvastatin tablets, Mylan Institutional
10 mg, 100 count (NDC 51079-0208-20)
20 mg, 100 count (NDC 51079-0209-20)
40 mg, 100 count (NDC 51079-0210-20)
80 mg, 30 count (NDC 51079-0211-03)
 
Atorvastatin tablets, Sandoz
10 mg, 90 count (NDC 00781-5381-92)
20 mg, 90 count (NDC 00781-5382-92)
 
Lipitor tablets, Pfizer
10 mg, 90 count (NDC 00071-0155-23)
10 mg, 100 count (NDC 00071-0155-40)
10 mg, 5000 count (NDC 00071-0155-34)
20 mg, 90 count (NDC 00071-0156-23)
20 mg, 100 count (NDC 00071-0156-40)
20 mg, 5000 count (NDC 00071-0156-94)
40 mg, 90 count (NDC 00071-0157-23)
40 mg, 100 count (NDC 00071-0157-40)
40 mg, 500 count (NDC 00071-0157-73)
40 mg, 2500 count (NDC 00071-0157-88)
80 mg, 64 count (NDC 00071-0158-92)
80 mg, 90 count (NDC 00071-0158-23)
80 mg, 500 count (NDC 00071-0158-73)
80 mg, 2500 count (NDC 00071-0158-88)

Estimated Resupply Dates

  • Apotex has all atorvastatin tablets on allocation.
  • Greenstone has atorvastatin tablets available but the company is allocating product to non-primary customers due to market supply constraints.
  • Sandoz has atorvastatin 40 mg and 80 mg tablets on back order and the company cannot estimate a release date. Check with your wholesaler for availability.

Related Shortages

Updated

May 20, April 8 and 27, March 18 and 24, February 5 and 20, January 16, 2015; December 9 and 22, October 10, September 16 and 3, June 12, April 9 and 25, March 12 and 20, February 25, January 6, 2014; December 6 and 19, November 11, October 2, 16, and 30, August 6, 13, and 27, July 3 and 25, June 18, May 10 and 15, April 3 and 23, March 8, 20, and 25, 2013, February 6 and 12, January 18, 2013, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement